Full-Time

Investigator I / II

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior, Expert

Bridgewater Township, NJ, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • A minimum of a Bachelor’s degree in engineering or related field or equivalent experience required. Advanced degree preferred.
  • A minimum of 5 years of operations or quality Assurance experience within a cGMP environment in the biotech/biopharma industry and Cell/Gene Therapy cGMP manufacturing experience preferred
  • Support writing of SOPs for Manufacturing and Quality Risk Assessments for existing and new/changed processes.
  • Ability to work independently and successfully, prioritize and manage multiple tasks simultaneously, integrate cross-functional issues and balance competing priorities effectively. Must be able to manage shifting priorities to meet critical deadlines in a fast paced and dynamic, growing environment.
  • Advanced knowledge in cGMP.
  • Ability to interpret results and situations and articulate recommendations for resolution.
  • Excellent verbal and written communication skills.
  • Experience with electronic document management systems.
  • Drive CAPA closures and follow up in Effectiveness checks.
  • An ability to build strong partnerships and effectively integrate with external collaborators to drive projects/programs forward in a matrixed environment.
  • Language: English
Responsibilities
  • Lead cross functional investigations independently from end to end.
  • Ensure thorough root cause analysis, impact assessment, and CAPA/EC determination.
  • Serves as Subject Matter Expert (SME) in preparation for and during internal and external regulatory audits (including FDA, EMEA).
  • Support coordination of data collection and trend analysis as requested by QA and Regulatory Affairs including the annual report and continued process verification (CPV)
  • Recognize and act on potential compliance issues and opportunities for process changes/improvement.
  • Provide technical expertise in the Technical Operations group, process knowledge of the cell and gene therapy manufacturing, including but not limited to deviations (Quality Issues), investigations, CAPA management.
  • Work cross functionally with SME's and Quality to ensure robustness of investigations, as well as accuracy and ensuring compliance.
  • Must have a strong knowledge and experience with cGMP, GCP, GLP, Quality and Compliance.
  • Must have strong authorship and be able to critically review investigations, interpret results and generate technical conclusion consistent with Quality risk management principles.
  • Must be able to effectively prepare communications with interpretation of data analysis and potential problems to management and the group with clarity and a high level of accuracy.
  • Must provide guidance to other associates in the interpretation of technical issues across an interdisciplinary team.
  • Must be action-oriented and customer-focused, building relationships, problem solving, planning and organizing, conflict management, resource allocation, coaching others and analytical thinking. Confident in making decisions for minor issues.
  • Must be nimble and an agile learner able to assimilate large amount of data quickly and simplify to coherent story to support an investigation.
  • Intermediate to advanced ability to interpret results and situations and articulate recommendations for resolution.
  • Teamwork and ability to work effectively across functional groups and teams to ensure requirements are met. Must be self-motivated and driven to independently seek out answers.
  • Willing to work on shift as required.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates within the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

20%

1 year growth

47%

2 year growth

106%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.

Help us improve and share your feedback! Did you find this helpful?